105 research outputs found

    A case of antiphospholipid syndrome following gastric signet ring cell adenocarcinoma

    Get PDF
    Objective: Rare disease Background: Antiphospholipid syndrome (APS) is a rare autoimmune disease characterized by arterial, venous, and small-vessel thrombosis, pregnancy-related morbidity and the presence of antiphospholipid antibodies such as an-ticardiolipin antibody, and/or anti-beta2-glycoprotein I. In the recent years, APS was observed in patients with solid tumors and the renal cancer, lung carcinoma and breast tumors were the most common tumors linked with APS. Case Report: A 53-year-old female presented with pain and pitting edema of left lower extremity that had begun 6 months prior to hospitalization. Deep vein thrombosis (DVT) in the popliteal vein diagnosed by Doppler ultrasonogra-phy and the patient was treated with heparin followed by warfarin. Following subdural hematoma, anticoagu-lant therapy was stopped, and the patient underwent craniotomy. One month later, the patient returned with pain and DVT diagnosed in its right leg. Laboratory tests showed high levels of lupus anticoagulant, IgM and IgG anticardiolipin antibodies. Following a high alkaline phosphatase, diffuse bone marrow involvement was found by whole body bone scan. Looking to find primary tumor, a large infilterable lesion in gastric was seen by endoscopic images, and biopsy histopathology showed a signet ring cell adenocarcinoma. The patient re-fused chemotherapy and died 6 months after diagnosis. Conclusions: APS is associated with gastric signet ring cell adenocarcinoma. © Am J Case Rep, 2020

    Micromechanics of fatigue in woven and stitched composites

    Get PDF
    The goal is to determine how microstructural factors, especially the architecture of microstructural factors, control fatigue damage in 3D reinforced polymer composites. Test materials were fabricated from various preforms, including stitched quasi-isotropic laminates, and through-the-thickness angle interlock, layer-to-layer angle interlock, and through-the-thickness stitching effect weaves. Preforms were impregnated with a tough resin by a special vacuum infiltration method. Most tests are being performed in uniaxial compression/compression loading. In all cases to date, failure has occurred not by delamination, but by shear failure, which occurs suddenly rather than by gradual macroscopic crack growth. Some theoretical aspects of bridging are also examined

    Micromechanics of fatigue in woven and stitched composites

    Get PDF
    The goals of this research program were to: (1) determine how microstructural factors, especially the architecture of reinforcing fibers, control stiffness, strength, and fatigue life in 3D woven composites; (2) identify mechanisms of failure; (3) model composite stiffness; (4) model notched and unnotched strength; and (5) model fatigue life. We have examined a total of eleven different angle and orthogonal interlock woven composites. Extensive testing has revealed that these 3D woven composites possess an extraordinary combination of strength, damage tolerance, and notch insensitivity in compression and tension and in monotonic and cyclic loading. In many important regards, 3D woven composites far outstrip conventional 2D laminates or stitched laminates. Detailed microscopic analysis of damage has led to a comprehensive picture of the essential mechanisms of failure and how they are related to the reinforcement geometry. The critical characteristics of the weave architecture that promote favorable properties have been identified. Key parameters are tow size and the distributions in space and strength of geometrical flaws. The geometrical flaws should be regarded as controllable characteristics of the weave in design and manufacture. In addressing our goals, the simplest possible models of properties were always sought, in a blend of old and new modeling concepts. Nevertheless, certain properties, especially regarding damage tolerance, ultimate failure, and the detailed effects of weave architecture, require computationally intensive stochastic modeling. We have developed a new model, the 'binary model,' to carry out such tasks in the most efficient manner and with faithful representation of crucial mechanisms. This is the final report for contract NAS1-18840. It covers all work from April 1989 up to the conclusion of the program in January 1993

    An engineering model of woven composites based on micromechanics

    Get PDF
    Composites with three-dimensional woven architectures exhibit large strains to failure when compared to composites made up of the same materials but not with three-dimensional interlocking tows. The fracture mechanics of such three-dimensional architectures is a subject requiring substantial investigation and experimental testing. Classical fracture mechanics concepts (for instance, an isolated defect in a homogeneous body) will not be applicable to the woven fracture test specimen. The use of an isolated singularity to characterize an entire specimen is inadequate when the density of defects is considerable and the material is heterogeneous. Modelling of such a complex system requires a great deal of insight and consideration as well as prudent choices of model sizes to make numerical schemes feasible. The purpose of this manuscript is to review our recently acquired knowledge of damage accumulation in woven composites and to describe a practicable model of the macroscopic behavior in these and other complex composite architectures based on such knowledge. In this manuscript, discussion will be limited to uniaxial compressive loading; considerations of general loading (monotonic and cyclic) will appear in a subsequent manuscript. Our modelling efforts may be briefly described as follows: the composite is subdivided into microstructural elements (microelements) in which the micromechanical modelling is either understood rigorously or can be represented adequately by statistical parameters. There can be microstructural elements for many different types of composite components, such as the various types of warp and weft and matrix for three-dimensional woven composites. The physical dimensions of microelements are made as large as possible while the response within the element can still be represented by a single micromechatlical calculation. The various elements are linked together(sometimes by associating distinct corners and edges, sometimes by superposition) in a pattern which resembles a particular weave architecture. The model can then be loaded in any manner and the linear and nonlinear elastic responses of representative weaves can be calculated. After the elastic regime, the fracture response is determined by monitoring the damage accumulation

    Mechanisms of compressive failure in woven composites and stitched laminates

    Get PDF
    Stitched laminates and angle interlock woven composites have been studied in uniaxial, in-plane, monotonic compression. Failure mechanisms have been found to depend strongly on both the reinforcement architecture and the degree of constraint imposed by the loading grips. Stitched laminates show higher compressive strength, but are brittle, possessing no load bearing capacity beyond the strain for peak load. Post-mortem inspection shows a localized shear band of buckled and broken fibers, which is evidently the product of an unstably propagating kink band. Similar shear bands are found in the woven composites if the constraint of lateral displacements is weak; but, under strong constraint, damage is not localized but distributed throughout the gauge section. While the woven composites tested are weaker than the stitched laminates, they continue to bear significant loads to compressive strains of approx. 15 percent, even when most damage is confined to a shear band

    Dopaminergic D1 receptor signalling is necessary, but not sufficient for cued fear memory destabilisation

    Get PDF
    Rationale. Pharmacological targeting of memory reconsolidation is a promising therapeutic strategy for the treatment of fear memory-related disorders. However, the success of reconsolidation-based approaches depends upon the effective destabilisation of the fear memory by memory reactivation. Objectives. Here, we aimed to determine the functional involvement of dopamine D1 receptors in cued fear memory destabilisation, using systemic drug administration. Results. We observed that direct D1 receptor agonism was not sufficient to stimulate tone fear memory destabilisation to facilitate reconsolidation disruption by the glucocorticoid receptor antagonist mifepristone. Instead, administration of the nootropic nefiracetam did facilitate mifepristone-induced amnesia, in a manner that was dependent upon dopamine D1 receptor activation, although. Finally, while the combined treatment with nefiracetam and mifepristone did not confer fear-reducing effects under conditions of extinction learning, there was some evidence that mifepristone reduces fear expression irrespective of memory reactivation parameters. Conclusions. The use of combination pharmacological treatment to stimulate memory destabilisation and impair reconsolidation has potential therapeutic benefits, without risking a maladaptive increase of fear

    Baseline characteristics of patients in the reduction of events with darbepoetin alfa in heart failure trial (RED-HF)

    Get PDF
    <p>Aims: This report describes the baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF) which is testing the hypothesis that anaemia correction with darbepoetin alfa will reduce the composite endpoint of death from any cause or hospital admission for worsening heart failure, and improve other outcomes.</p> <p>Methods and results: Key demographic, clinical, and laboratory findings, along with baseline treatment, are reported and compared with those of patients in other recent clinical trials in heart failure. Compared with other recent trials, RED-HF enrolled more elderly [mean age 70 (SD 11.4) years], female (41%), and black (9%) patients. RED-HF patients more often had diabetes (46%) and renal impairment (72% had an estimated glomerular filtration rate <60 mL/min/1.73 m2). Patients in RED-HF had heart failure of longer duration [5.3 (5.4) years], worse NYHA class (35% II, 63% III, and 2% IV), and more signs of congestion. Mean EF was 30% (6.8%). RED-HF patients were well treated at randomization, and pharmacological therapy at baseline was broadly similar to that of other recent trials, taking account of study-specific inclusion/exclusion criteria. Median (interquartile range) haemoglobin at baseline was 112 (106–117) g/L.</p> <p>Conclusion: The anaemic patients enrolled in RED-HF were older, moderately to markedly symptomatic, and had extensive co-morbidity.</p&gt

    A review of the positive and negative effects of cardiovascular drugs on sexual function: a proposed table for use in clinical practice

    Get PDF
    Several antihypertensive drugs, such as diuretics and β-blockers, can negatively affect sexual function, leading to diminished quality of life and often to noncompliance with the therapy. Other drug classes, however, such as angiotensin II receptor blockers (ARBs) are able to improve patients’ sexual function. Sufficient knowledge about the effects of these widely used antihypertensive drugs will make it possible for cardiologists and general practitioners to spare and even improve patients’ sexual health by switching to different classes of cardiac medication. Nevertheless, previous data (part I) indicate that most cardiologists lack knowledge about the effects cardiovascular agents can have on sexual function and will thus not be able to provide the necessary holistic patient care with regard to prescribing these drugs. To be able to improve healthcare on this point, we aimed to provide a practical overview, for use by cardiologists as well as other healthcare professionals, dealing with sexual dysfunction in their clinical practices. Therefore, a systematic review of the literature was performed. The eight most widely used classes of antihypertensive drugs have been categorised in a clear table, marking whether they have a positive, negative or no effect on sexual function
    corecore